Benzinga - Tue, 09 Mar 2021 06:03:09 -0400
Benzinga - Mon, 08 Mar 2021 14:09:14 -0400
Benzinga - Mon, 08 Mar 2021 13:01:53 -0400
Benzinga - Mon, 08 Mar 2021 11:22:39 -0400
Benzinga - Mon, 08 Mar 2021 09:12:19 -0400
Benzinga - Thu, 18 Feb 2021 06:07:42 -0400
Benzinga - Wed, 17 Feb 2021 07:03:17 -0400
Benzinga - Tue, 16 Feb 2021 09:03:44 -0400
load more
Sector: Health Care.Industry: Biotechnology
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes IMVT-1401 targets the neonatal Fc receptor (FcRn).

Earnings

see more
Q4 2021Est.ActualSurprise
EPS
(EXPECTED)2021-06-28
REV
Q3 2021Est.ActualSurprise
EPS-0.320
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
IMVTImmunovant0.61%1.6B

Immunovant Company Questions & Answers

Q

How do I buy Immunovant (IMVT) stock?

A

You can purchase shares of Immunovant (NASDAQ: IMVT) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Immunovant's (IMVT) main competitors?

Q

What is the target price for Immunovant?

A

The latest price target for Immunovant (NASDAQ: IMVT) was reported by Credit Suisse on 2021-02-17. The analyst firm set a price target for 26.00 expecting IMVT to rise to within 12 months (a possible 57.58% upside). 18 analyst firms have reported ratings in the last year.

Q

How much is Immunovant (IMVT) stock ?

A

The stock price for Immunovant (NASDAQ: IMVT) is $16.5 last updated Today at 2:51:00 PM.

Q

When is the next Immunovant (IMVT) dividend?

A

There are no upcoming dividends for Immunovant.

Q

When is Immunovant (NASDAQ:IMVT) reporting earnings?

A
Immunovant’s Q4 earnings are confirmed from now on June 28, 2021.
Q

When is the upcoming split for IMVT?

A

There is no upcoming split for Immunovant.